Table 2.
Sample characteristics of the prostate and testicular cancer survivor samples
| PCa survivors (N = 116) | TCa survivors (N = 126) | |||
|---|---|---|---|---|
| Age | ||||
| Mean ± SD (years) | 75.0 | (5.8) | 43.1 | (8.8) |
| Civil status (%) | ||||
| married/living with partner | 92 | (79%) | 85 | (67%) |
| widower | 11 | (10%) | – | |
| divorced/separated | 8 | (7%) | 7 | (6%) |
| in relationship living apart | – | 15 | (12%) | |
| never been married/living together | 4 | (3%)a | 16 | (13%) |
| Education (%) | ||||
| university | 23 | (20%) | 42 | (33%) |
| vocational education | 46 | (40%) | 50 | (40%) |
| high school | 24 | (21%) | 26 | (21%) |
| primary school | 21 | (18%) | 6 | (5%) |
| Work status (%) | ||||
| fulltime (≥ 32 h per week) | 2 | (2%) | 92 | (73%) |
| part-time (< 32 h per week) | 1 | (1%) | 13 | (10%) |
| irregular hours | 1 | (1%) | – | |
| retired | 111 | (96%) | 6 | (5%) |
| unemployed | – | 2 | (2%) | |
| incapable of work | 1 | (1%) | 9 | (7%) |
| household | – | 2 | (2%) | |
| Country (%) | ||||
| The Netherlands | 44 | (38%) | 37 | (29%) |
| Belgium | 37 | (32%) | – | |
| United Kingdom | – | 29 | (23%) | |
| Norway | – | 23 | (18%) | |
| France | 25 | (22%) | – | |
| Italy | 10 | (9%) | 37 | (29%) |
| Time since treatment allocation | ||||
| Mean (SD) (years) | 13.0 | (2.1) | – | |
| Time since treatment evaluation | ||||
| Mean (SD) (years) | – | 11.9 | (3.8) | |
| Treatment allocation (%) | ||||
| prostatomectomy and wait and see | 53 | (46%) | – | |
| prostatomectomy and radiation | 61 | (53%) | – | |
| four cycles/ five days | – | 27 | (21%) | |
| four cycles/ three days | – | 23 | (18%) | |
| three cycles/ five days | – | 53 | (42%)b | |
| three cycles/ three days | – | 23 | (18) | |
| Co-morbid disorders (%) | ||||
| 0 | 22 | (19%) | 58 | (46%) |
| 1 | 22 | (19%) | 36 | (29%) |
| 2 | 29 | (25%) | 20 | (16%) |
| 3 or more | 35 | (30%) | 8 | (6%) |
aTotals which do not add up to 100% are caused by missing data. bMost patients recruited outside the trial were treated with this regimen. N number of participants, SD Standard deviation